CN103829249A - 一种调理脾胃湿热体质酵素及其制备方法 - Google Patents
一种调理脾胃湿热体质酵素及其制备方法 Download PDFInfo
- Publication number
- CN103829249A CN103829249A CN201410099189.4A CN201410099189A CN103829249A CN 103829249 A CN103829249 A CN 103829249A CN 201410099189 A CN201410099189 A CN 201410099189A CN 103829249 A CN103829249 A CN 103829249A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- spleen
- ferment
- days
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000952 spleen Anatomy 0.000 title claims abstract description 56
- 210000002784 stomach Anatomy 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 title abstract description 15
- 108090000790 Enzymes Proteins 0.000 title abstract description 15
- 230000003750 conditioning effect Effects 0.000 title abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 23
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 19
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 18
- 235000020224 almond Nutrition 0.000 claims abstract description 18
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 17
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 17
- 241000722885 Brettanomyces Species 0.000 claims abstract description 17
- 235000019095 Sechium edule Nutrition 0.000 claims abstract description 17
- 240000004713 Pisum sativum Species 0.000 claims abstract description 16
- 235000010582 Pisum sativum Nutrition 0.000 claims abstract description 16
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 241001138401 Kluyveromyces lactis Species 0.000 claims abstract description 12
- 241000228347 Monascus <ascomycete fungus> Species 0.000 claims abstract description 12
- 244000057717 Streptococcus lactis Species 0.000 claims abstract description 12
- 235000014897 Streptococcus lactis Nutrition 0.000 claims abstract description 12
- 239000000725 suspension Substances 0.000 claims abstract description 11
- 238000000855 fermentation Methods 0.000 claims description 79
- 230000004151 fermentation Effects 0.000 claims description 74
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 29
- 230000003203 everyday effect Effects 0.000 claims description 25
- 238000003756 stirring Methods 0.000 claims description 25
- 241001655322 Streptomycetales Species 0.000 claims description 22
- 230000001105 regulatory effect Effects 0.000 claims description 20
- 238000005286 illumination Methods 0.000 claims description 18
- 238000001228 spectrum Methods 0.000 claims description 18
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 17
- 240000005265 Lupinus mutabilis Species 0.000 claims description 16
- 235000008755 Lupinus mutabilis Nutrition 0.000 claims description 16
- 241000223253 Rhodotorula glutinis Species 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 14
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 14
- 240000001851 Artemisia dracunculus Species 0.000 claims description 14
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 14
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 14
- 239000001138 artemisia absinthium Substances 0.000 claims description 14
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 14
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 13
- 244000077995 Coix lacryma jobi Species 0.000 claims description 13
- 244000241838 Lycium barbarum Species 0.000 claims description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 13
- 241001557517 Crocanthemum scoparium Species 0.000 claims description 12
- 230000009286 beneficial effect Effects 0.000 claims description 9
- 238000012423 maintenance Methods 0.000 claims description 9
- 239000002893 slag Substances 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 2
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 claims 1
- 241000628997 Flos Species 0.000 claims 1
- 235000021185 dessert Nutrition 0.000 claims 1
- 244000005706 microflora Species 0.000 claims 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 3
- 240000005250 Chrysanthemum indicum Species 0.000 abstract description 2
- 235000013291 Alisma plantago aquatica Nutrition 0.000 abstract 1
- 240000004615 Alisma plantago-aquatica Species 0.000 abstract 1
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 241000223252 Rhodotorula Species 0.000 abstract 1
- 240000007660 Sechium edule Species 0.000 abstract 1
- 241000187747 Streptomyces Species 0.000 abstract 1
- 241000187436 Streptomyces globisporus Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 238000010411 cooking Methods 0.000 abstract 1
- 235000021332 kidney beans Nutrition 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
- 230000006870 function Effects 0.000 description 20
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 235000013305 food Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- -1 10 milligrams Chemical compound 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 2
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000004922 Vigna radiata Species 0.000 description 2
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 2
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- QMCLOHXDDPMAMI-UHFFFAOYSA-N alisol B Natural products CC(C)C(=O)C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1 QMCLOHXDDPMAMI-UHFFFAOYSA-N 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 244000046738 asparagus lettuce Species 0.000 description 2
- 235000006705 asparagus lettuce Nutrition 0.000 description 2
- 230000036523 atherogenesis Effects 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000002478 diastatic effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 2
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical compound C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- HNOSJVWYGXOFRP-UHFFFAOYSA-N Alisol A Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(O)C(C)(C)O)C)CCC21C HNOSJVWYGXOFRP-UHFFFAOYSA-N 0.000 description 1
- WXHUQVMHWUQNTG-UHFFFAOYSA-N Alisol E 24-acetate Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(OC(C)=O)C(C)(C)O)C)CCC21C WXHUQVMHWUQNTG-UHFFFAOYSA-N 0.000 description 1
- NLOAQXKIIGTTRE-UHFFFAOYSA-N Alisol-B-Monoacetat Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CCC=1C(C)CC(OC(C)=O)C1OC1(C)C NLOAQXKIIGTTRE-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- DORJGGFFCMZTHW-KXVAGGRESA-N C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O Chemical compound C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O DORJGGFFCMZTHW-KXVAGGRESA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LNSXRXFBSDRILE-UHFFFAOYSA-N Cucurbitacin Natural products CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(C)(C)C(O)C(O)CC4(C)C3(C)C(=O)CC12C LNSXRXFBSDRILE-UHFFFAOYSA-N 0.000 description 1
- CVKKIVYBGGDJCR-SXDZHWHFSA-N Cucurbitacin B Natural products CC(=O)OC(C)(C)C=CC(=O)[C@@](C)(O)[C@@H]1[C@@H](O)C[C@]2(C)C3=CC[C@@H]4C(C)(C)C(=O)[C@H](O)C[C@@]4(C)[C@@H]3CC(=O)[C@@]12C CVKKIVYBGGDJCR-SXDZHWHFSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 101100276976 Drosophila melanogaster Drak gene Proteins 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WXHUQVMHWUQNTG-JSWHPQHOSA-N [(3r,4s,6r)-2,4-dihydroxy-6-[(5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] acetate Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](OC(C)=O)C(C)(C)O)C)CC[C@@]21C WXHUQVMHWUQNTG-JSWHPQHOSA-N 0.000 description 1
- NLOAQXKIIGTTRE-CXWFPJGHSA-N [1-(3,3-dimethyloxiran-2-yl)-3-[(8s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] acetate Chemical compound C([C@]1(C)[C@@]2(C)CCC3C(C)(C)C(=O)CC[C@]3(C)C2[C@@H](O)CC1=1)CC=1C(C)CC(OC(C)=O)C1OC1(C)C NLOAQXKIIGTTRE-CXWFPJGHSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- DORJGGFFCMZTHW-UHFFFAOYSA-N alisol C Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC(=O)C=1C(C)CC(O)C1OC1(C)C DORJGGFFCMZTHW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000001904 cucurbitacins Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- PIGAXYFCLPQWOD-UHFFFAOYSA-N dihydrocucurbitacin I Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)CCC(C)(O)C)C(O)CC3(C)C1CC=C1C2C=C(O)C(=O)C1(C)C PIGAXYFCLPQWOD-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N octadec-8-enoic acid Chemical compound CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及了一种调理脾胃湿热体质酵素及其制备方法;其原料成分:A1.杏仁10%、黑芝麻10%、薏苡仁15%,A2.豌豆15%、芸豆15%、茵陈3%、菊花3%、冬瓜10%,佛手瓜10%,泽泻3%、枸杞3%、甘草3%;益生菌由C1:红曲霉、粘红酵母、白拟球酵母,C2:酒香酵母、团片链霉菌、产黑链霉菌,C3:乳酸克鲁维酵母,乳酸链球菌组成的益生菌,其制备方法如下:1、将上述原料中A1浸泡蒸熟接种C1发酵7天后接种C2发酵7天;2、将A2材料粉碎接种C1,C2发酵14天;3、将1与2发酵后用1:1比例混合,接种C3发酵90天后所得悬液即为调理脾胃湿热体质酵素;本发明具有祛热利湿、健脾整胃的效果。
Description
技术领域
本发明涉及一种调理脾胃湿热体质酵素及其制备方法,属于保健食品技术领域。
背景技术
脾胃湿热症的形成虽然有多种病因,但决定的因素为脾胃功能的正常与否,当脾胃虚弱,不能正常运化水谷之物,水反为湿,谷反为滞,湿和滞久蕴结后则化热,便可形成湿热;同时各种疾病因素很易引发脾胃功能失调而生湿热。因此其病因有三方面:1.感受外邪:由于脾胃的生理特性,湿邪和燥邪易侵犯脾胃。脾为阴脏为湿土,为“受湿之区”,湿邪最易伤脾;胃为阳脏五行为土故为燥土,喜润恶燥,易患燥病,燥为阳热之邪,燥甚则热,胃热脾湿结合即为湿热。六淫的其他外邪如外感风热,在脾虚失运内有蕴湿的情况下,外感风热与内蕴之湿,结合亦成湿热。正如薛生白所云:“太阳内伤,湿饮停聚,客邪再致,内外相引,故病湿热。”同时外邪犯肺,胸闷咳嗽,气机升降失常,又可伤及虚弱之脾胃,致湿从内生,郁而化热,形成湿热。2.饮食不节:无节制的饮食是伤害脾胃的最多最常见的病因。“饮食自倍,脾胃乃伤”。嗜酒、过饱、过食肥甘厚味及不洁的饮食,无规律的饮食均易伤及脾胃,引起食滞、湿阻、气滞等,而食滞、湿阻、气滞日久均可化热。酒性本身即“气热而质湿”,气滞也是水湿停聚的重要因素,肥甘厚味极具生湿助热的特性,可见诸多饮食不节因素均可成为脾胃湿热证形成的病因,胃虽喜润恶燥,但脾胃湿热的形成与胃也有直接的关系。食物先由胃纳,临床常先见胃纳失常的症状如胃脘痞满、纳呆、恶心等。脾与胃共为中土,生理上协调合作,共同完成纳化功能,病理上互相影响,所以湿热证与胃的关系密不可分,故称脾胃湿热证。3.情志因素:“脾在志为思”,“思则气结”。张景岳曾说:“但苦思难释则伤脾”。过度思虑,情志不畅,会影响肝的疏泄功能,肝的正常疏泄是脾升胃降协调脾气健运的重要条件,即“土得木而达”。肝失疏泄无以调畅气机,脾升胃降失调,脾失健运生湿,湿郁化热,湿热乃成。上述病因在不同的个体会引起不同的脾胃病证,这是由个体的体质素质不同,脾胃功能性状不同,对病因作用反应的形式不同所决定的。
脾胃湿热的人容易常有腹胀、呕恶、厌食、肢体困重、大便溏泻、小便短赤不清、或面目肌肤发黄、色鲜明如橘子,皮肤发痒,或身热起伏,汗出而热不解,黄疸、胆囊炎、甚至者更有胃肠方面的肿瘤发生,这些病症的原因皆为脾,胃的环境提供一个给细胞或体内的有害菌生长的最佳环境,将身体内的环境改善了,自然丛病部生。
如何调理脾胃的环境呢?体内的湿热是脾胃湿热体质的最佳表现,所以调养湿热体质的最根本问题是如何清热祛湿,中医养生讲究七法,就是养神、养气、居养、形养、食疗、药调、和术养七中方法,其中的药调是运用养生药剂进行调养祛湿,其制剂多为纯天然植物药,制法也都为粗加工调剂,其剂型也多与食物相融合,因此中医称为药膳,其中的食养为中医养生方法的主要方法之一,它相对来说较为安全,适用人群也较多,主要为养生食品的选配调制与应用,以级饮食方法与节制等。本发明本着中医的食养法,采用天然有机种植的植物配合微生物发酵特性,本着调理脾胃湿热发生的原因用清热不碍利湿,利湿不助热的原则,调配出一种制取含有丰富的活性酶,维生素,矿物质和微生物的次生产物,酶中含有蛋白酶,脂肪酶和超氧化物歧化酶的调理脾胃湿热体质酵素。
发明内容
本发明是提供一种以杏仁、黑芝麻、薏苡仁、豌豆、芸豆、茵陈、菊花、冬瓜,佛手瓜,泽泻、枸杞、甘草经由益生菌群发酵后制取出调理肝胆湿热体质酵素。
(1)、材料配比:杏仁10%、黑芝麻10%、薏苡仁15%、豌豆15%、芸豆15%、茵陈3%、菊花3%、冬瓜10%,佛手瓜10%,泽泻3%、枸杞3%、甘草3%;
(2)、益生菌群:红曲霉1份、粘红酵母1-2份、白拟球酵母1-2份、酒香酵母2份、团片链霉菌0.2份、产黑链霉菌0.2-0.4份、乳酸克鲁维酵母3-4份,乳酸链球菌1-2份组成的益生菌;
(3)发酵制备流程:
(3-1)、将杏仁、黑芝麻、薏苡仁,用75℃水浸泡4H后各自用蒸锅蒸90分钟,然后用25℃水水浴,待材料冷却后,盖上纱布保湿备用。
(3-2)、将3-1)步骤完成后的放入发酵釜中,投入红曲霉、粘红酵母,进行醇化发酵,发酵时间7天,温度维持在25-32℃之间,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光,期间保持发酵釜中的通风量,并于每日太阳升起地平线时依逆时钟搅拌7次,太阳落地平线时依据顺时针方向搅拌7次;
(3-3)、将3-2)步骤发酵完成后,在原发酵釜中再投入酒香酵母、团片链霉菌、产黑链霉菌进行二次发酵,发酵期间7天,温度维持在35-40℃;
(3-4)、将豌豆、芸豆、茵陈、菊花、冬瓜,佛手瓜,泽泻、枸杞、甘草,用粉碎机粉碎成泥状,放入发酵釜中,投入粘红酵母、白拟球酵母进行醇化发酵,发酵14天,保持发酵釜的温度在28-30℃,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光;
(3-5)、取3-3)与3-4)步骤完成后的悬液与材料渣,以1:1的比例混合,投入酒香酵母进行醋化发酵,发酵期间30天,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(3-6)、将3-5)步骤发酵完成后再投入乳酸克鲁维酵母,乳酸链球菌进行乳酸化发酵,发酵期间30天,保持发酵温度25-28℃之间,发酵期间在每日早上3-10点与12-21点之间照射光谱在450与670两种光谱,照度在1500流明的灯光,每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(3-7)、用3000目滤网过滤3-6)步骤发酵后的残渣,所制取的悬液即为调理肝胆湿热体质酵素;
本发明的材料详细如下:
杏仁:富含丰富的维生素、蛋白质和铁、钙等微量矿物质,对人体是非常具有补充所需营养的作用。杏仁中包含着不饱和脂肪可以在补充人体所需的脂肪需要时而不增加其他多余的脂肪,杏仁富含的膳食纤维元素对降低人体的胆固醇、三高人群都具有很好地帮助作用。
黑芝麻:含有大量的脂肪和蛋白质,还有糖类、维生素A、维生素E、卵磷脂、钙、铁、铬等营养成分,黑芝麻的营养成分中还包括了极其珍贵的芝麻素和黑色素等物质,具有健胃、保肝、促进红细胞生长的作用。
薏苡仁:含有薏苡仁酯(coixenolide);并含脂肪油,油中含肉豆蔻酸(myristic acid)、芸苔甾醇(campesterol)、棕榈酸、8-十八烯酸、豆甾醇等,尚含氨基酸、蛋白质、糖类,有健脾渗湿,除痹止泻。用于水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻的功效。
豌豆:豌豆味甘、性平,归脾、胃经,具有益中气、止泻痢、调营卫、利小便、消痈肿、解乳石毒之功效。对脚气、痈肿、乳汁不通、脾胃不适、呃逆呕吐、心腹胀痛、口渴泄痢等病症。豌豆荚和豆苗的嫩叶中富含维生素C和能分解体内亚硝胺的酶,可以分解亚硝胺。
芸豆:每百克菜豆含蛋白质23.1克、脂肪1.3克、碳水化合物56.9克、钙76毫克及丰富的B族维生素,鲜豆还含丰富的维生素C,另外芸豆含有皂苷、尿毒酶和多种球蛋白等独特成分,具有提高人体免疫能力、增强抗病能力、激活淋巴细胞,促进脱氧核糖核酸的合成等功能。
茵陈:可预防流感,治中暑、感冒、头痛身重、腹痛、呕吐、胸膈胀满、气阻食滞、小儿食积腹胀、腹泻、月经过多、崩漏带下、皮肤搔痒及水肿等症,其散热发表功用,尤胜于薄荷,全草又可提芳香油,鲜茎叶含油0.07-0.2%,干茎叶含油0.15-4%,油的比重(15℃)0.868-0.910,旋光度(20℃)-20°-70°,含醇量(以香草醇计)2-3%,含酚量(以麝香草酚计)约含7%茵陈清热利湿;退黄。主治:黄疸、小便不利、湿疮瘙痒、传染性黄疸型肝炎。药理学研究有利胆,保护肝功能,解热,抗炎,降血脂,降压,扩冠等作用。
菊花:具有疏风、清热、明目、解毒之功效。主要治疗头痛、眩晕、目赤、心胸烦热、疔疮、肿毒等症。现代药理研究表明,菊花具有治疗冠心病、降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老等多种药理活性。
冬瓜:冬瓜中的不少化学成份具有显著的生理活性。冬瓜果肉含有腺嘌呤、β-谷甾醇、羽扇豆醇、十三烷醇、甘露醇、鼠李糖、葫芦素β等多种功能性成份。冬瓜瓤含葫芦巴碱(tfigonelline)、组氨酸、腺嘌呤、维生素B1、C、E等。冬瓜皮含蜡类及树脂类物质等。冬瓜籽含皂甙0.6%,尿素、尿素分解酶、脂肪油、瓜氨酸、组氨酸、蛇麻脂醇,甘露醇,β-谷甾醇等,尤其以维生素B1含量相当丰富。具有解毒、利水消痰、除烦止渴、祛湿解暑。用于心胸烦热、小便不利、肺痈咳喘、肝硬化腹水、利尿消肿、高血压等功效。
佛手瓜:佛手瓜肉质细嫩,每100克佛手瓜的果实 中含有水分90—92克,蛋白质0.9—1.2克,碳水化合物2.6—7.7克,维生素C12—22毫克,胡萝卜素20微克。钾的含量较高,可达190毫克,核黄素0.1毫克,钙500毫克、磷320毫克、铁40毫克、钠10毫克、铜0.03毫克、镁7毫克、锌8.35微克硒2.3微克。此外还含有叶酸、泛酸、烟酸等。佛手瓜的苗也是营养丰富的蔬菜,每百克鲜苗含有蛋白质1.8克、脂肪0.5克、碳水化合物4.3克、钙20毫克,磷10毫克、铁14毫克,特别是硒的含量每100克含30.58-53.01微克,具有理气和中,疏肝止咳的作用,适宜于消化不良、胸闷气胀、呕吐、肝胃气痛以及气管炎咳嗽多痰者食用。
泽泻:块茎含泻醇A、B、C、泽泻醇A单乙酸酯,泽泻醇B单乙酸酯,泽泻醇C单乙酸醋表泽泻醇A,泽泻薁醇,泽泻薁醇氧化物,16β-甲氧基泽泻醇B单乙酸酯,16β-羟基泽泻醇B单乙酸酯,谷甾醇-3-O-硬脂酰基 -β-D-吡喃葡萄糖甙。还含胆碱,糖和钾、钙、镁等元素。现代医学研究,泽泻可降低血清总胆固醇及三酰甘油含量,减缓动脉粥样硬化形成;泽泻及其制剂现代还用于治疗内耳眩晕症、血脂异常、遗精、脂肪肝及糖尿病等,具有利水渗湿;泄热通淋.主小便不利;热淋涩痛;水肿胀满;泄泻;痰饮眩晕;遗精,可降低血清总胆固醇及三酰甘油含量,减缓动脉粥样硬化形成,
枸杞:含甜菜碱(betane),阿托品(atropine),天仙子胺,功效具有养肝,滋肾,润肺。枸杞叶:补虚益精,清热明目。
甘草:甘草含有多种化学成分,主要成分有甘草酸、甘草甙等。甘草的化学组成极为复杂,目前为止从甘草中分离出的化合物有甘草甜素、甘草次酸、甘草甙、异甘草甙、新甘草甙、新异甘草甙、甘草素、异甘草素以及甘草西定、甘草醇、异甘草醇、7-甲基香豆精、伞形花内酯等数十种化合物,大量的研究表明,甘草甜素和黄酮类物质是甘草中最重要的生理活性物质。具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
本发明的优点:
本发明提供的发酵方法,是应用各种常见的豆类,蔬菜,中药的各种性征,采用中医的药膳同源理论,合理配伍制,配合益生菌群里的各种菌种的发酵特性与同化特性,应用材料本身具有的微量元素提供给微生物生长所需的元素,并在每一发酵阶段期间,创造各种微生物不同的生长环境特性,配合大自然在早晨太阳初升起时的阴阳两气的气场进行搅拌,以吸收大自然的气场精华,提供适合微生物工作时配合特定的光波与音波增强微生物的功能将,上述的原材料经过醇化,醋化、醇化的发酵阶段,发酵出具有活性调理脾胃湿热体质酵素,所采用的材料为药膳同源的有机食材,含有丰富的活性酶,维生素,矿物质和微生物的次生产物,酶中含有蛋白酶,脂肪酶和超氧化物歧化酶是本益生菌群的主要功效酶,提供给因为生活与工作无法改善自我本身体质的人群,预防因脾胃湿热而引发的各种的症状。
附图说明
图1、一种调理脾胃湿热体质酵素及其制备方法:
S11:浸泡 S12:蒸熟 S13:糖化发酵 S14:醇化发酵
S21:材料粉碎成泥 S22:醇化发酵
S23:醋化发酵 S24:酯化发酵
S25:过滤灭菌 S26:装罐。
具体实施方式
下面结合具体附图和实施例对本发明的一种调理脾胃湿热体质酵素及其制备方法做进一步说明,下列实例说明不涉及本专利的保护范围
实施例1
材料配比:杏仁10%、黑芝麻10%、薏苡仁15%、豌豆15%、芸豆15%、茵陈3%、菊花3%、冬瓜10%,佛手瓜10%,泽泻3%、枸杞3%、甘草3%;
益生菌群:红曲霉、粘红酵母、白拟球酵母、酒香酵母、团片链霉菌、产黑链霉菌、乳酸克鲁维酵母,乳酸链球菌组成的益生菌。
本发明的工艺流程:
(S11)、将杏仁、黑芝麻、薏苡仁,用75℃水浸泡4H后;
(S12)、将S11)步骤完成后各自用蒸锅蒸90分钟蒸熟,后用25℃水水浴,待材料冷却后,盖上纱布保湿备用;
(S13)、将S12)步骤完成后的材料放入发酵釜中,投入红曲霉、粘红酵母,进行糖化发酵,发酵时间7天,温度维持在25-30℃之间,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光;
(S14)、将S13)步骤发酵完成后,在原发酵釜中再投入酒香酵母、团片链霉菌、产黑链霉菌进行醇化发酵,发酵期间7天,温度维持在35-40℃;
(S21)、将豌豆、芸豆、茵陈、菊花、冬瓜,佛手瓜,泽泻、枸杞、甘草,用粉碎机粉碎成泥状,湿度80-90%、放入玻璃发酵釜中;
(S22)、将S21)步骤的材料放入发酵釜中,接种粘红酵母、白拟球酵母进行醇化发酵,发酵14天,保持发酵釜的温度在28-30℃,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光进行醇化发酵,发酵10天;
(S23)、将S14)与S22)步骤完成后的悬液与材料渣,以1:1的比例混合,接种酒香酵母进行醋化发酵,发酵期间30天,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(S24)、将S23)步骤发酵完成后再投入乳酸克鲁维酵母,乳酸链球菌进行乳酸化发酵,发酵期间30天,保持发酵温度25-28℃之间,发酵期间在每日早上3-10点与12-21点之间照射光谱在450与670两种光谱,照度在1500流明的灯光,每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(S25)、用3000目滤网过滤C2)步骤发酵后的残渣,后用121℃蒸汽灭菌30分钟;
(S26)、将S5)灭菌后的悬液装入棕色玻璃瓶即为调理调脾胃湿热体质酵素;
实施例2
材料配比:杏仁10%、黑芝麻10%、薏苡仁15%、豌豆15%、芸豆15%、茵陈3%、菊花3%、冬瓜10%,佛手瓜10%,泽泻3%、枸杞3%、甘草3%;
益生菌群:红曲霉、粘红酵母、白拟球酵母、酒香酵母、团片链霉菌、产黑链霉菌、乳酸克鲁维酵母,乳酸链球菌组成的益生菌。
(A1)、将杏仁、黑芝麻、薏苡仁,用清水浸泡18H;
(A2)、将A1)步骤完成后的材料放入发酵釜中,投入红曲霉、粘红酵母,酒香酵母、团片链霉菌、产黑链霉菌,进行醋化化发酵,发酵时间14天,温度维持在30℃之间;
(B1)、将豌豆、芸豆、茵陈、菊花、冬瓜,佛手瓜,泽泻、枸杞、甘草,用粉碎机粉碎成泥状,加入蒸馏水、放入玻璃发酵釜中,水的高度以淹没材料10CM;
(B2)、进一步接种粘红酵母、白拟球酵母进行醇化发酵,发酵14天,保持发酵釜的温度在28℃,发酵14天,保持发酵釜的温度在25-28℃,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光;
(C1)、将A4)与B2)步骤完成后的悬液与材料渣,以1:1的比例混合,接种酒香酵母进行醋化发酵,发酵期间30天,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(C2)、将C1)步骤发酵完成后再投入乳酸克鲁维酵母,乳酸链球菌进行乳酸化发酵,发酵期间30天,保持发酵温度25-28℃之间,发酵期间在每日早上3-10点与12-21点之间照射光谱在450与670两种光谱,照度在1500流明的灯光,每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(C3)、用3000目滤网过滤C2)步骤发酵后的残渣,所制取的悬液即为调理脾胃湿热体质酵素。
实施例3
材料配比:杏仁10%、绿豆仁10%、薏苡仁15%、豌豆15%、芸豆15%、茵陈3%、玫瑰花3%,莴笋10%,佛手瓜10%,泽泻3%、枸杞3%、甘草3%;
益生菌群:红曲霉、粘红酵母、白拟球酵母、酒香酵母、团片链霉菌、产黑链霉菌、乳酸克鲁维酵母,乳酸链球菌组成的益生菌。
(A1)、将杏仁、绿豆仁、薏苡仁,用清水浸泡18H,用蒸笼蒸熟,放置阴凉处自然冷却到30℃以下;
(A2)、将A1)步骤完成后的材料放入发酵釜中,投入红曲霉、粘红酵母,酒香酵母、团片链霉菌、产黑链霉菌,进行醋化发酵,发酵时间14天,温度维持在30℃之间;
(B1)、将豌豆、芸豆、茵陈、玫瑰花、莴笋、佛手瓜、泽泻、枸杞、甘草,用粉碎机粉碎成泥状,加入蒸馏水、放入玻璃发酵釜中,水的高度以淹没材料10CM;
(B2)、进一步接种粘红酵母、白拟球酵母进行醇化发酵,发酵14天,保持发酵釜的温度在28℃,发酵14天,保持发酵釜的温度在25-28℃,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光;
(C1)、将A2)与B2)步骤完成后的悬液与材料渣,以1:1的比例混合,接种酒香酵母进行醋化发酵,发酵期间30天,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;;
(C2)、将C1)步骤发酵完成后再投入乳酸克鲁维酵母,乳酸链球菌进行乳酸化发酵,发酵期间30天,保持发酵温度25-28℃之间,发酵期间在每日早上3-10点与12-21点之间照射光谱在450与670两种光谱,照度在1500流明的灯光,每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(C3)、用3000目滤网过滤C2)步骤发酵后的残渣,所制取的悬液即为调理脾胃湿热体质酵素。
本发明的调理脾胃湿热体质酵素具有降低血脂、减少血液胆固醇的含量,舒肝理气、健脾利湿,利肠胃,益肾补元的功能;解决因为脾胃湿热引起的胃脘疼痛,嘈杂灼热,口干不欲饮,饥而不欲食,小便色黄,大便不畅等症状,食用方法:用调理脾胃湿热体质酵素与30-35℃的温开水以1:10的比例稀释后于早晚各饮用一次,每次200ml;本发明的功效是用微生物发酵的功能,制取出材料中的各种适合脾、胃、肝、肾,肺的的活性营养元素并含有对人体新陈代谢的活性酶,可以帮助健脾益肥,清利湿,清热利湿法、美白肌肤、增强机体代谢功能,预防脾胃湿热发生,本品适合大部分青中年人使用,禁用人群:妊娠中妇女。
虽然本发明已以较佳实施例揭示如上,然其并非用以限定本发明,任何本领域技术人员,在不脱离本发明的精神和范围内,当可作些许的修改和完善,因此本发明的保护范围当以权利要求书所界定的为准。
Claims (5)
1.一种调理脾胃湿热体质酵素及其制备方法,其特征是:以杏仁、黑芝麻、薏苡仁、豌豆、芸豆、茵陈、菊花、冬瓜,佛手瓜,泽泻、枸杞、甘草经由益生菌群发酵后制取出调理脾胃湿热体质酵素。
2.一种调理脾胃湿热体质酵素及其制备方法,其特征采用以下工艺步骤:
(A1)、材料配比:杏仁10%、黑芝麻10%、薏苡仁15%、豌豆15%、芸豆15%、茵陈3%、菊花3%、冬瓜10%、佛手瓜10%、泽泻3%、枸杞3%、甘草3%;
(A2)、益生菌群:红曲霉1份、粘红酵母1-2份、白拟球酵母1-2份、酒香酵母2份、团片链霉菌0.2份、产黑链霉菌0.2-0.4份、乳酸克鲁维酵母3-4份、乳酸链球菌1-2份组成的益生菌;
(A3)、将杏仁、黑芝麻、薏苡仁、用75℃水浸泡4H后各自用蒸锅蒸90分钟,然后用25℃水水浴,待材料冷却后,盖上纱布保湿备用;
(A4)、将A3)步骤完成后的放入发酵釜中,投入红曲霉、粘红酵母,进行醇化发酵,发酵时间7天,温度维持在25-32℃之间,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光,期间保持发酵釜中的通风量,并于每日太阳升起地平线时依逆时钟搅拌7次,太阳落地平线时依据顺时针方向搅拌7次;
(A5)、将A4)步骤发酵完成后,在原发酵釜中再投入酒香酵母、团片链霉菌、产黑链霉菌进行二次发酵,发酵期间7天,温度维持在35-40℃;
(A6)、将豌豆、芸豆、茵陈、菊花、冬瓜,佛手瓜,泽泻、枸杞、甘草,用粉碎机粉碎成泥状,放入发酵釜中,投入粘红酵母、白拟球酵母进行醇化发酵,发酵14天,保持发酵釜的温度在28-30℃,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光;
(A7)取A5)与A6)步骤完成后的悬液与材料渣,以1:1的比例混合,投入酒香酵母进行醋化发酵,发酵期间30天,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(A8)、将A7)步骤发酵完成后再投入乳酸克鲁维酵母,乳酸链球菌进行乳酸化发酵,发酵期间30天,保持发酵温度25-28℃之间,发酵期间在每日早上3-10点与12-21点之间照射光谱在450与670两种光谱,照度在1500流明的灯光,每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(A9)、用3000目滤网过滤发酵后的残渣,所制取的悬液即为调理脾胃湿热体质酵素。
3.如权利要求2所述的一种调理脾胃湿热体质酵素及其制备方法,其特征是:所述发酵菌群由红曲霉、粘红酵母、白拟球酵母、酒香酵母、团片链霉菌、产黑链霉菌、乳酸克鲁维酵母,乳酸链球菌份组成的益生菌。
4.如权利要求2所述的一种调理脾胃湿热体质酵素及其制备方法,其特征是:所述杏仁为甜杏仁,苦杏仁的果肉,茎叶,果仁的一种或多种。
5.如权利要求2所述的一种调理脾胃湿热体质酵素及其制备方法,其特征是:所述的菊花为昆仑雪菊,杭白菊的一种或多种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410099189.4A CN103829249A (zh) | 2014-03-18 | 2014-03-18 | 一种调理脾胃湿热体质酵素及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410099189.4A CN103829249A (zh) | 2014-03-18 | 2014-03-18 | 一种调理脾胃湿热体质酵素及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103829249A true CN103829249A (zh) | 2014-06-04 |
Family
ID=50793399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410099189.4A Pending CN103829249A (zh) | 2014-03-18 | 2014-03-18 | 一种调理脾胃湿热体质酵素及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103829249A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651185A (zh) * | 2015-02-15 | 2015-05-27 | 大连工业大学 | 抗雾霾浆果酵素含汽山楂酒及其制备方法 |
CN105056135A (zh) * | 2015-08-21 | 2015-11-18 | 徐伟明 | 一种针对于气滞血瘀体质调理的中药复合酵素及其制备方法 |
CN105559068A (zh) * | 2015-12-31 | 2016-05-11 | 浙江省林业科学研究院 | 一种利用食药真菌发酵三叶青获得的组合物及其制备方法 |
CN107660788A (zh) * | 2016-07-28 | 2018-02-06 | 莫艳清 | 一种冬瓜酵素及其制备方法 |
CN112841661A (zh) * | 2021-02-01 | 2021-05-28 | 贵州菊春堂农业科技发展有限公司 | 一种菊花益生元的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001095529A (ja) * | 1999-09-28 | 2001-04-10 | Takashi Sakamoto | アロエミネラルによる機能性食品 |
CN102669658A (zh) * | 2012-04-23 | 2012-09-19 | 浙江科技学院 | 一种植物酵素食品的制备方法 |
CN102742911A (zh) * | 2012-07-25 | 2012-10-24 | 曹庆荣 | 酵素凉茶及其制备方法 |
CN103393121A (zh) * | 2013-06-17 | 2013-11-20 | 湖北富程祥云生物科技有限公司 | 一种改善胃肠功能,含酶复合益生菌植物酵素的制备方法 |
CN103520551A (zh) * | 2013-10-24 | 2014-01-22 | 新时代健康产业(集团)有限公司 | 一种湿热体质保健食品及其制备方法 |
-
2014
- 2014-03-18 CN CN201410099189.4A patent/CN103829249A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001095529A (ja) * | 1999-09-28 | 2001-04-10 | Takashi Sakamoto | アロエミネラルによる機能性食品 |
CN102669658A (zh) * | 2012-04-23 | 2012-09-19 | 浙江科技学院 | 一种植物酵素食品的制备方法 |
CN102742911A (zh) * | 2012-07-25 | 2012-10-24 | 曹庆荣 | 酵素凉茶及其制备方法 |
CN103393121A (zh) * | 2013-06-17 | 2013-11-20 | 湖北富程祥云生物科技有限公司 | 一种改善胃肠功能,含酶复合益生菌植物酵素的制备方法 |
CN103520551A (zh) * | 2013-10-24 | 2014-01-22 | 新时代健康产业(集团)有限公司 | 一种湿热体质保健食品及其制备方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651185A (zh) * | 2015-02-15 | 2015-05-27 | 大连工业大学 | 抗雾霾浆果酵素含汽山楂酒及其制备方法 |
CN105056135A (zh) * | 2015-08-21 | 2015-11-18 | 徐伟明 | 一种针对于气滞血瘀体质调理的中药复合酵素及其制备方法 |
CN105559068A (zh) * | 2015-12-31 | 2016-05-11 | 浙江省林业科学研究院 | 一种利用食药真菌发酵三叶青获得的组合物及其制备方法 |
CN105559068B (zh) * | 2015-12-31 | 2018-04-06 | 浙江省林业科学研究院 | 一种利用食药真菌发酵三叶青获得的组合物及其制备方法 |
CN107660788A (zh) * | 2016-07-28 | 2018-02-06 | 莫艳清 | 一种冬瓜酵素及其制备方法 |
CN112841661A (zh) * | 2021-02-01 | 2021-05-28 | 贵州菊春堂农业科技发展有限公司 | 一种菊花益生元的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103393121B (zh) | 一种改善胃肠功能、含酶复合益生菌植物酵素的制备方法 | |
CN103027231B (zh) | 一种复合益生菌发酵中草药活性保健液及其制备方法 | |
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN101624570B (zh) | 中药培养养殖肉灵芝方法及养殖肉灵芝保健品的制备方法 | |
CN106722963A (zh) | 一种素食餐 | |
CN109805232A (zh) | 大枣三段式益生菌发酵生产低酸度微生态食品 | |
CN106072578A (zh) | 具有增强人体免疫功能的酵素组合物、泡腾片及制法 | |
CN101603010A (zh) | 一种肉灵芝快速培育方法 | |
CN106420847A (zh) | 辅助保护胃黏膜和/或缓解胃胀的组合物及其微生态制剂 | |
CN105249109A (zh) | 一种改善儿童胃肠功能,富含复合益生菌植物酵素饮品的制备方法 | |
CN103829249A (zh) | 一种调理脾胃湿热体质酵素及其制备方法 | |
CN106822766A (zh) | 一种祛湿健脾的中药组分及其制备方法 | |
CN106418525A (zh) | 一种发酵型桑叶咀嚼片及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN109528814A (zh) | 一种乳酸菌发酵黄芪的微生态制剂及其制备方法和应用 | |
CN106343567A (zh) | 一种诺丽果口服液及其制备方法 | |
CN102021101B (zh) | 可防治心脑血管疾病的益寿养生酒的制备方法 | |
CN105685620A (zh) | 一种辣木口服液及其制备方法 | |
CN103238757B (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN1203168C (zh) | 一种制备食疗保健醋的方法及用该方法生产的食疗保健醋 | |
CN103829248A (zh) | 一种调理肝胆湿热体质酵素及其制备方法 | |
CN105288226A (zh) | 一种补肾壮阳的组合物及其制备方法 | |
CN105602787A (zh) | 一种蜂蛹虫草保健酒及其制备方法和应用 | |
CN107536061B (zh) | 复合益生菌膳食纤维以及其制备方法 | |
CN102488744A (zh) | 一种解酒毒的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140604 |